
Overview
Yolanda Mageto, MD, MPH, a pulmonary critical care specialist with nationally recognized expertise in interstitial lung disease (ILD), has assumed the role of Medical Director of Interstitial Lung Disease at Baylor University Medical Center at Dallas. Dr. Mageto attended medical school at Washington University in St. Louis, Missouri and completed her residency and training at University of Texas Southwestern and her fellowship in pulmonary and critical care medicine at the University of Washington in Seattle with a focus in ILD. Since that time she has held faculty positions at the University of Washington Seattle, University of Texas Southwestern and most recently University of Vermont where she rose to the rank of full Professor. Dr. Mageto is a clinician, educator and researcher involved in multiple idiopathic pulmonary fibrosis/ILD trials over last 20 years including collaborations with investigators from other centers in sarcoidosis related lung disease. She remains actively involved in the total care and management of her patients. Dr. Mageto is dedicated to the development of a Comprehensive Integrated Interstitial Lung disease program optimizing delivery of care to patients with interstitial lung disease in the Dallas Fort Worth Area. In her spare time she enjoys spending time with her family, travelling, reading a good book and cooking.
Dr. Mageto is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Acute Interstitial Pneumonia, Interstitial Lung Disease, Pulmonary Fibrosis, and Hypersensitivity Pneumonitis.
Dr. Mageto is board certified in Pulmonary Disease- American Board Of Internal Med/Pulmonary Disease and Pulmonary Disease- American Board Of Internal Medicine. She is actively involved in clinical research, co-authoring 13 peer reviewed articles and participating in 5 clinical trials.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- POS
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
3410 Worth St, Ste 250, Dallas, TX 75246
1420 8th Ave, Ste 103, Fort Worth, TX 76104
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
5 Clinical Trials
Baylor Scott & White Liver Consultants Of Texas-Dallas
Dr James is a Transplant Surgeon practicing medicine in Dallas, Texas. Dr. James is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Nonalcoholic Steatohepatitis (NASH), Hepatitis, Non-Alcoholic Fatty Liver Disease, Liver Transplant, and Kidney Transplant.
Baylor Scott & White Liver Consultants Of Texas - Waxahachie
Sumeet Asrani, MD, MSc is the Chief of Hepatology and Liver Transplantation at the Baylor Simmons Transplant Institute in Dallas. He has served as the Medical Director of the Center for Advanced Liver Disease since 2016. He provides clinical care at Baylor University Medical Center (BUMC) and Baylor Scott and White Medical Center – Waxahachie. Recently, Dr. Asrani has restructured the research enterprise of the Simmons Transplant Institute and has been instrumental in elevating the name of the Institute and Baylor Scott & White as a recognized presence in the national and international academic world. Dr. Asrani received his medical degree from Baylor College of Medicine in Houston. He did his internship and residency at Washington University School of Medicine in St. Louis, MO. He went on to complete fellowships in gastroenterology, hepatology and transplant hepatology at the Mayo Clinic in Rochester, Minnesota before joining the transplant hepatology team at Baylor University Medical Center in 2013. Dr. Asrani has published 140 peer review publications, 300 abstracts and given over 125 national and international presentations. In addition, he has mentored more than 30 trainees to help advance their medical careers. Dr. Asrani previously served as an associate editor for the American Journal of Transplantation (AJT) and as an associate editor for Liver Transplantation (LT). He is actively involved in national and international collaborations to improve care for patients with liver disease. Dr. Asrani specializes in the management of patients with end-stage liver disease, liver transplantation candidates and recipients. His other clinical interests include liver cancer, viral hepatitis, autoimmune hepatitis, primary sclerosing cholangitis and alcohol associated liver disease. His research interests focus on early identification of patients with cirrhosis, improving quality of patients with liver disease especially in the rural setting, improving kidney function in patients with liver disease and organ allocation. In his free time, Dr, Asrani enjoys various fitness endeavors, playing the drums, and traveling with his wife and four children. Dr. Asrani was recognized by D Magazine as a Best Doctor for 2023, 2024 and 2025. Dr. Asrani is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Liver Failure, Ascites, Hepatitis, Liver Transplant, and Endoscopy. Dr. Asrani is board certified in Gastroenterology- American Board Of Internal Med/Gastroenterology, Transplant Hepatology- American Board Of Internal Med/Transplant Hepatology, Transplant Hepatology- American Board Of Internal Medicine, and Gastroenterology- American Board Of Internal Medicine.
Baylor Scott & White Liver Consultants Of Texas - Dallas
"Dr. Rahimi is board certified in transplant hepatatology, gastroenterology and internal medicine. His clinical interests include chronic liver disease, liver cancer, liver failure, metabolic and autoimmune diseases of the liver, viral hepatitis, complications of cirrhosis and liver transplantation. Dr. Rahimi has authored several research articles on improving the outcomes of patients with advanced liver disease. Dr. Rahimi holds a Master of Science in Applied Physiology from Finch University of Health Sciences in North Chicago and medical degree from Chicago Medical School. While completing his internship and residency in Internal Medicine at the University of Virginia in Charlottesville, VA, he concurrently obtained a Master of Science in Clinical Research in the Department of Public Health. Upon relocating to Dallas, Dr. Rahimi completed two fellowships, the first in Gastroenterology at the University of Texas Southwestern Medical Center followed by a fellowship in Transplant Hepatology at Baylor University Medical Center, part of Baylor Scott & White Health, in Dallas. Read more about Dr. Rahimi’s publications on PubMed.gov and the Baylor Health Sciences Library . Read Dr. Rahimi's article, ""5 things you need to know about fatty liver disease (and how to reverse it)"" . Dr. Rahimi is involved in a study around the use of statins in patients with advanced liver failure and cirrhosis. Read more here . Dr. Rahimi was recognized by D Magazine as a Best Doctor for 2024 and 2025. Read Dr. Rahimi's article, ""Can fatty liver be reversed? 5 common questions, answered.""". Dr. Rahimi is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Liver Failure, Esophageal Varices, Ascites, Liver Transplant, and Hepato-Pancreato-Biliary Surgery. Dr. Rahimi is board certified in Gastroenterology- American Board Of Internal Med/Gastroenterology, Transplant Hepatology- American Board Of Internal Med/Transplant Hepatology, Gastroenterology- American Board Of Internal Medicine, and Transplant Hepatology- American Board Of Internal Medicine.
Frequently Asked Questions about Dr. Yolanda Mageto
How do I make an appointment with Dr. Yolanda Mageto?
You can book an appointment with Dr. Yolanda Mageto by calling their office at 214-820-6856. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Yolanda Mageto a top-rated expert for Acute Interstitial Pneumonia?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Yolanda Mageto is classified as an Distinguished expert for Acute Interstitial Pneumonia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Yolanda Mageto specialize in?
While Dr. Yolanda Mageto is a Pulmonary Medicine, they have specific expertise in Acute Interstitial Pneumonia, Interstitial Lung Disease, and Pulmonary Fibrosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pulmonary Medicine.
Does Dr. Yolanda Mageto participate in research or clinical trials?
Yes. Dr. Yolanda Mageto has published 13 articles and abstracts on conditions like Acute Interstitial Pneumonia. You can view a list of Dr. Yolanda Mageto's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Yolanda Mageto accept my insurance?
Dr. Yolanda Mageto accepts most major insurance plans, including Aetna and Baylor Scott & White Health. We recommend calling the office directly at 214-820-6856 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Interstitial PneumoniaDr. Mageto isDistinguished. Learn about Acute Interstitial Pneumonia.
- Hypersensitivity PneumonitisDr. Mageto isDistinguished. Learn about Hypersensitivity Pneumonitis.
- Idiopathic Pulmonary FibrosisDr. Mageto isDistinguished. Learn about Idiopathic Pulmonary Fibrosis.
- Interstitial Lung DiseaseDr. Mageto isDistinguished. Learn about Interstitial Lung Disease.
- Lung MetastasesDr. Mageto isDistinguished. Learn about Lung Metastases.
- PneumoniaDr. Mageto isDistinguished. Learn about Pneumonia.
- Advanced
- Bronchogenic CystDr. Mageto isAdvanced. Learn about Bronchogenic Cyst.
- Cholesterol PneumoniaDr. Mageto isAdvanced. Learn about Cholesterol Pneumonia.
- EmphysemaDr. Mageto isAdvanced. Learn about Emphysema.
- NeurosarcoidosisDr. Mageto isAdvanced. Learn about Neurosarcoidosis.
- SarcoidosisDr. Mageto isAdvanced. Learn about Sarcoidosis.
- Experienced
- Allergic Bronchopulmonary AspergillosisDr. Mageto isExperienced. Learn about Allergic Bronchopulmonary Aspergillosis.
- Alpha-1 Antitrypsin Deficiency (AATD)Dr. Mageto isExperienced. Learn about Alpha-1 Antitrypsin Deficiency (AATD).
- AspergillosisDr. Mageto isExperienced. Learn about Aspergillosis.
- AsthmaDr. Mageto isExperienced. Learn about Asthma.
- Asthma in ChildrenDr. Mageto isExperienced. Learn about Asthma in Children.
- BronchiectasisDr. Mageto isExperienced. Learn about Bronchiectasis.

